Cha Soung-Chul, Kwak Larry W, Ruffini Pier Adelchi, Qin Hong, Neelapu Sattva, Biragyn Arya
Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 0903, Houston, TX 77030, USA.
J Immunol Methods. 2006 May 30;312(1-2):79-93. doi: 10.1016/j.jim.2006.02.013. Epub 2006 Mar 31.
Active immunization of follicular lymphoma patients with idiotypic vaccines elicits antigen-specific antibody responses, T-cell responses, and antitumor effects. We hypothesized that these vaccinated patients could generate tumor-specific immune responses, not only against idiotype, but also against other tumor-associated antigens (TAA) by a mechanism of epitope spreading. To identify potential antigens, a phage surface expressed cDNA library derived from primary tumor cells was screened with sera from idiotype-vaccinated patients. Consistent with our hypothesis, we identified two immunogenic peptides (FL-aa-7 and 18), unrelated to idiotype, which were recognized by postvaccine sera but not by prevaccine or normal human sera. These peptide sequences derived from the 5'-untranslated regions of the human GTPase, IMAP family member 7 gene (FL-aa-7) and an alternative reading frame of U1-snRNP 70 (FL-aa-18), respectively, suggesting that epitope spreading had occurred.
用独特型疫苗对滤泡性淋巴瘤患者进行主动免疫可引发抗原特异性抗体反应、T细胞反应及抗肿瘤效应。我们推测,这些接种疫苗的患者不仅可通过表位扩展机制产生针对独特型的肿瘤特异性免疫反应,还可产生针对其他肿瘤相关抗原(TAA)的免疫反应。为鉴定潜在抗原,我们用独特型疫苗接种患者的血清筛选了源自原发性肿瘤细胞的噬菌体表面表达cDNA文库。与我们的假设一致,我们鉴定出两种与独特型无关的免疫原性肽(FL-aa-7和18),它们可被接种疫苗后的血清识别,但不能被接种疫苗前的血清或正常人血清识别。这些肽序列分别源自人GTP酶IMAP家族成员7基因(FL-aa-7)的5'-非翻译区和U1-snRNP 70的一个可读框(FL-aa-18),提示发生了表位扩展。